CVE-2011-3386
NVD-CWE-noinfoPublished: September 2, 2011· Updated: Jun 16, 2026
Official Description
Unspecified vulnerability in Medtronic Paradigm wireless insulin pump 512, 522, 712, and 722 allows remote attackers to modify the delivery of an insulin bolus dose and cause a denial of service (adverse human health effects) via unspecified vectors involving wireless communications and knowledge of the device's serial number, as demonstrated by Jerome Radcliffe at the Black Hat USA conference in August 2011. NOTE: the vendor has disputed the severity of this issue, saying "we believe the risk of deliberate, malicious, or unauthorized manipulation of medical devices is extremely low... we strongly believe it would be extremely difficult for a third-party to wirelessly tamper with your insulin pump... you would be able to detect tones on the insulin pump that weren't intentionally programmed and could intervene accordingly."
Technical Analysis
CVE-2011-3386 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CVSS v3.1 Vector Breakdown
Affected Vendors & Products
Exploit & PoC Resources
All References (16)
Quick Facts
Related CVEs (NVD-CWE-noinfo)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2011-3386 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts